Liver Cancer Trial, Recruiting NCT05185245 Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT05185245
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Your original colorectal (colon or rectal) cancer tumor was fully removed with surgery, leaving no cancer cells at the edges of the removed tissue
  • You have cancer that has spread to the liver that cannot be removed with surgery, either from the start or after previous liver surgery
  • Scans and a camera test of your colon have confirmed that your original cancer has not come back in its original location
  • Scans have confirmed that the cancer has not spread to any parts of your body outside the liver
  • You are generally in good health and able to carry out daily activities with little or no limitation
  • Your blood test shows your white blood cell (neutrophil) count is above a certain level (confirm with trial site for exact number)
  • You have already received at least one course of chemotherapy for at least 3 months, and your cancer either shrank or stayed stable during that treatment
  • Your blood level of a cancer marker called CEA (a protein sometimes raised in colorectal cancer) is either below a certain level or has dropped by at least half from its highest recorded level
  • You have given written agreement to take part in the trial
  • You have no other medical reasons that would prevent you from receiving a liver transplant

Who may not be able to join:

  • You have been diagnosed with another type of cancer
  • Your original colorectal cancer has come back in the same place it started
  • Your cancer has spread to parts of the body other than the liver
  • You have not received any chemotherapy treatment before joining the trial
  • Your original tumor was only partially removed (for comfort rather than cure)
  • The trial doctors have identified any other reason they feel makes it unsuitable for you to take part (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Registry
ClinicalTrials.gov
Start date
1 April 2021
Est. completion
30 March 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Overall Survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov